CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 4DMedical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

4DMedical Ltd
Level 7, 700 Swanston Street, Carlton
Phone: +61 395455940p:+61 395455940 MELBOURNE, VIC  VIC 3053  Australia Ticker: 4DX4DX

Business Summary
4DMedical Limited is an Australia-based medical technology company specializing in advanced diagnostic imaging solutions. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. It produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20256/30/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board LilianBianchi 11/2/2023 12/11/2019
Chief Executive Officer, Managing Director, Executive Director AndreasFouras
Interim Chief Financial Officer ChrisCox 3/26/2025 3/25/2025
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 465,540,474 (As of 6/30/2025)
Shareholders: 9,051
Stock Exchange: ASX


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025